On this page
GAMT
guanidinoacetate N-methyltransferase
The GAMT gene provides instructions for an enzyme essential for the second step of creatine production, a compound vital for energy storage and nervous system function. GAMT encodes guanidinoacetate N-methyltransferase, an enzyme primarily active in the liver.
GAMT is located on the short (p) arm of chromosome 19, at band 19p13.3. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 19 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The GAMT gene, or guanidinoacetate N-methyltransferase, is responsible for producing an enzyme that plays a crucial role in the body's energy metabolism. This enzyme is primarily found in the liver and is involved in the synthesis of creatine, a compound vital for storing and utilising energy within cells.
Creatine is particularly important for providing energy to muscles and supporting the proper functioning of the nervous system. Understanding the GAMT gene and its associated enzyme is therefore key to comprehending certain metabolic pathways and related health conditions.
What the gene does
The GAMT gene provides the blueprint for the guanidinoacetate N-methyltransferase enzyme. This enzyme is mainly expressed in the liver and is a key player in the two-step process of creatine synthesis. Creatine is built from the amino acids glycine, arginine, and methionine.
Specifically, the GAMT enzyme catalyses the second step of this pathway, converting guanidinoacetate into creatine. Creatine is indispensable for the body's energy management, supplying energy for muscle contraction and supporting brain function. Beyond its primary role in creatine synthesis, the guanidinoacetate N-methyltransferase enzyme is also thought to contribute to activating fatty acid oxidation, a process that provides cellular energy during periods of glucose scarcity or stress.
Video: Genetics 101
Chromosome location
The GAMT gene is situated on chromosome 19, specifically at position 19p13.3. This location refers to the short (p) arm of chromosome 19, within band 13.3. The precise genomic coordinates help geneticists locate and study the gene within the human genome.
Protein structure
The guanidinoacetate N-methyltransferase protein, encoded by the GAMT gene, consists of 236 amino acids. It contains a significant functional region known as the RMT2 domain, which spans from amino acids 13 to 236. This domain is integral to the enzyme's methyltransferase activity, allowing it to perform its catalytic role in creatine synthesis.
Key variants
Genetic variations, known as variants, in the GAMT gene can alter the function of the guanidinoacetate N-methyltransferase enzyme. These changes can range from single base pair substitutions to larger deletions or insertions within the gene sequence. Such variants may lead to a reduced or absent enzyme function, impacting the body's ability to produce creatine.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.194T>C | p.Leu65Pro | Pathogenic | ★★★☆ | Deficiency of guanidinoacetate methyltransferase |
c.235C>T | p.Gln79Ter | Pathogenic | ★★★☆ | Deficiency of guanidinoacetate methyltransferase |
c.352G>T | p.Glu118Ter | Pathogenic | ★★★☆ | Deficiency of guanidinoacetate methyltransferase |
c.391G>C | p.Gly131Arg | Pathogenic | ★★★☆ | Deficiency of guanidinoacetate methyltransferase |
c.403G>T | p.Asp135Tyr | Pathogenic | ★★★☆ | Deficiency of guanidinoacetate methyltransferase |
c.418_419del | p.Ser140fs | Pathogenic | ★★★☆ | Deficiency of guanidinoacetate methyltransferase |
c.432G>A | p.Trp144Ter | Pathogenic | ★★★☆ | Deficiency of guanidinoacetate methyltransferase |
c.497T>C | p.Leu166Pro | Pathogenic | ★★★☆ | Deficiency of guanidinoacetate methyltransferase |
c.526dup | p.Glu176fs | Pathogenic | ★★★☆ | Deficiency of guanidinoacetate methyltransferase |
c.590T>C | p.Leu197Pro | Pathogenic | ★★★☆ | Deficiency of guanidinoacetate methyltransferase |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Variants in the GAMT gene are primarily associated with cerebral creatine deficiency. This is an inherited metabolic disorder characterised by the body's inability to synthesise sufficient creatine due to impaired function of the guanidinoacetate N-methyltransferase enzyme. This can lead to a range of neurological symptoms.
UK clinical status
The GAMT gene is recognised within several NHS Genomic Medicine Service national test directories, indicating its clinical significance in the UK. It is categorised as 'green' in panels such as DDG2P, Early onset or syndromic epilepsy, Intellectual disability, Likely inborn error of metabolism (R98), and Undiagnosed metabolic disorders, highlighting its role in these conditions.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the main function of the GAMT gene?
The GAMT gene provides instructions for an enzyme called guanidinoacetate N-methyltransferase, which is crucial for the second step in the production of creatine. Creatine is vital for storing and using energy, particularly in muscles and the nervous system.
What happens if the GAMT gene doesn't work correctly?
If the GAMT gene has variants that impair its function, the body cannot produce enough creatine. This can lead to a condition called cerebral creatine deficiency, which primarily affects brain function and can cause intellectual disability and seizures.
Where in the body is the GAMT enzyme most active?
The guanidinoacetate N-methyltransferase enzyme, encoded by the GAMT gene, is primarily active in the liver. This is where most of the body's creatine synthesis takes place.
References
- Mercimek-Mahmutoglu S, Ndika J, Kanhai W. Thirteen new patients with guanidinoacetate methyltransferase deficiency and functional characterization of nineteen novel missense variants in the GAMT gene. Human mutation. 2014. PMID: 24415674
- Braissant O, Henry H, Béard E. Creatine deficiency syndromes and the importance of creatine synthesis in the brain. Amino acids. 2011. PMID: 21390529
- Gordon N. Guanidinoacetate methyltransferase deficiency (GAMT). Brain & development. 2010. PMID: 19289269
- Nasrallah F, Feki M, Kaabachi N. Creatine and creatine deficiency syndromes: biochemical and clinical aspects. Pediatric neurology. 2010. PMID: 20159424
- Béard E, Braissant O. Synthesis and transport of creatine in the CNS: importance for cerebral functions. Journal of neurochemistry. 2010. PMID: 20796169
- Dhar SU, Scaglia F, Li FY. Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency. Molecular genetics and metabolism. 2009. PMID: 19027335
- Ide T, Brown-Endres L, Chu K. GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress. Molecular cell. 2009. PMID: 19917247
- Almeida LS, Vilarinho L, Darmin PS. A prevalent pathogenic GAMT mutation (c.59G>C) in Portugal. Molecular genetics and metabolism. 2007. PMID: 17336114
- Leuzzi V, Carducci C, Carducci C. A mutation on exon 6 of guanidinoacetate methyltransferase (GAMT) gene supports a different function for isoform a and b of GAMT enzyme. Molecular genetics and metabolism. 2006. PMID: 16293431
- Sykut-Cegielska J, Gradowska W, Mercimek-Mahmutoglu S. Biochemical and clinical characteristics of creatine deficiency syndromes. Acta biochimica Polonica. 2004. PMID: 15625559
- Schulze A. Creatine deficiency syndromes. Molecular and cellular biochemistry. 2003. PMID: 12701824
- Stöckler S, Holzbach U, Hanefeld F. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatric research. 1994. PMID: 7808840